Previous close | 2.0000 |
Open | 1.3300 |
Bid | 2.5000 |
Ask | 5.9000 |
Strike | 45.00 |
Expiry date | 2024-09-20 |
Day's range | 1.3300 - 2.0000 |
Contract range | N/A |
Volume | |
Open interest | 19 |
Oppenheimer & Co. Inc. (Oppenheimer) — a leading investment bank, wealth manager and a subsidiary of Oppenheimer Holdings (NYSE: OPY) — announced today that Kunal Bhatia joined as a Managing Director in the firm's Healthcare Investment Banking Group. He will be based in New York and report to Michael Margolis, R.Ph, Oppenheimer's Co-Head of Healthcare and Head of Healthcare Life Sciences Investment Banking.
Key Insights Insiders appear to have a vested interest in Oppenheimer Holdings' growth, as seen by their sizeable...
Oppenheimer Europe (Oppenheimer) — a subsidiary of Oppenheimer Holdings, the leading investment bank and wealth manager (NYSE: OPY) — announced today a further expansion of its European investment banking footprint with the addition of Martin Chamberlin.